U.S. High Growth Tech and AI Stocks

Travere Therapeutics

Market Cap: US$1.8b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Lumentum Holdings

Market Cap: US$4.5b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

TG Therapeutics

Market Cap: US$5.3b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Alkami Technology

Market Cap: US$3.0b

Provides cloud-based digital banking solutions in the United States.

Alnylam Pharmaceuticals

Market Cap: US$32.7b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

AVITA Medical

Market Cap: US$184.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Ascendis Pharma

Market Cap: US$9.1b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Super Micro Computer

Market Cap: US$19.1b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

Ardelyx

Market Cap: US$866.1m

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Clene

Market Cap: US$22.7m

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.

Blueprint Medicines

Market Cap: US$6.3b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

Legend Biotech

Market Cap: US$5.8b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Red Cat Holdings

Market Cap: US$536.7m

Provides products and solutions to drone industry in the United States.

Palantir Technologies

Market Cap: US$276.8b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

CoreWeave

Market Cap: US$23.8b

Operates a cloud platform that provides scaling, support, and acceleration for GenAI.

Bitdeer Technologies Group

Market Cap: US$2.8b

Operates as a technology company for blockchain and computing.

Silence Therapeutics

Market Cap: US$174.7m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Workday

Market Cap: US$69.3b

Provides enterprise cloud applications in the United States and internationally.

Exelixis

Market Cap: US$10.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Zscaler

Market Cap: US$36.1b

Operates as a cloud security company worldwide.

Duos Technologies Group

Market Cap: US$85.6m

Designs, develops, deploys, and operates intelligent technology solutions in North America.

MeiraGTx Holdings

Market Cap: US$433.3m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

UroGen Pharma

Market Cap: US$478.5m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Vanda Pharmaceuticals

Market Cap: US$232.8m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Nutanix

Market Cap: US$20.0b

Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

Spotify Technology

Market Cap: US$132.9b

Provides audio streaming subscription services worldwide.

ARS Pharmaceuticals

Market Cap: US$1.3b

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Checkpoint Therapeutics

Market Cap: US$349.3m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

Pagaya Technologies

Market Cap: US$1.1b

A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services and other service providers, their customers, and asset investors in the United States, Israel, and the Cayman Islands.

ACADIA Pharmaceuticals

Market Cap: US$2.9b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Capricor Therapeutics

Market Cap: US$289.6m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Similarweb

Market Cap: US$633.6m

Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.

Roadzen

Market Cap: US$58.8m

Operates as an insurance technology company.

Aldeyra Therapeutics

Market Cap: US$130.6m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

TeraWulf

Market Cap: US$1.2b

Operates as a digital asset technology company in the United States.

Abeona Therapeutics

Market Cap: US$255.8m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.